Karyopharm Therapeutics
KPTI
#9262
Rank
โ‚น9.02 B
Marketcap
โ‚น529.07
Share price
2.43%
Change (1 day)
-46.04%
Change (1 year)

Market capitalization of Karyopharm Therapeutics (KPTI)

Market cap: โ‚น9.02 Billion

As of December 2025 Karyopharm Therapeutics has a market cap of โ‚น9.02 Billion. This makes Karyopharm Therapeutics the world's 9262th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Karyopharm Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น9.02 B18.88%
2024โ‚น7.58 B-7.99%
2023โ‚น8.24 B-74.11%
2022โ‚น31.85 B-11.9%
2021โ‚น36.15 B-56.61%
2020โ‚น83.32 B-6.76%
2019โ‚น89.36 B124.23%
2018โ‚น39.85 B37.81%
2017โ‚น28.92 B9.77%
2016โ‚น26.34 B-16.58%
2015โ‚น31.57 B-59.29%
2014โ‚น77.57 B85.15%
2013โ‚น41.89 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Karyopharm Therapeutics was reported to be:

โ‚น9.02 Billion
by Nasdaq info icon info icon
โ‚น9.02 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
โ‚น22.196 T 245,948.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น9.448 T 104,637.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น19.087 T 211,483.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น1.019 T 11,203.70%๐Ÿ‡บ๐Ÿ‡ธ USA